Inactive Instrument

Pharmagest Interactive SA Stock Swiss Exchange

Equities

FR0000077687

IT Services & Consulting

End-of-day quote Swiss Exchange
- EUR - Intraday chart for Pharmagest Interactive SA

Financials

Sales 2024 * 226M 247M 338M Sales 2025 * 244M 266M 364M Capitalization 746M 813M 1.11B
Net income 2024 * 46M 50.15M 68.6M Net income 2025 * 52M 56.69M 77.55M EV / Sales 2024 * 3.18 x
Net cash position 2024 * 26.05M 28.4M 38.85M Net cash position 2025 * 58.62M 63.91M 87.43M EV / Sales 2025 * 2.82 x
P/E ratio 2024 *
15.8 x
P/E ratio 2025 *
14.2 x
Employees -
Yield 2024 *
2.65%
Yield 2025 *
2.88%
Free-Float 32.21%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 55 90-12-31
Founder 65 96-01-24
Director of Finance/CFO - 22-12-31
Members of the board TitleAgeSince
Founder 65 96-01-24
Director/Board Member 47 17-06-26
Director/Board Member 59 99-12-31
More insiders
Equasens is No. 1 in France for publishing and integrating software programs for pharmacies, hospitals, healthcare facilities, laboratories, retirement homes and healthcare professionals. Net sales break down by activity as follows: - pharmacy software publishing and integration (74%): software programs for managing data bases, information, inventories, orders, electronic care records, etc.; - publishing of IT solutions for health and medical/social establishments (14.2%): publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, billing, receipt and accounting management, care management, supply management, etc.); - development of solutions and infrastructures for e-Health (11.8%): digital communication, telemedicine and telehealth solutions. The group also offers financing solutions for leased goods (Nanceo). Net sales are distributed geographically as follows: France (89.7%), Italy (5.4%), Belgium (2.9%), Germany (1%), the United Kingdom (0.8%) and Ireland (0.2%).
More about the company